Liver Flashcards

1
Q

Jaundice, cholestasis
Hypoalbuminemia
Hypoglycemia
Hyperammonia (defective urea cycle function)
Palmar erythema (local vasodilation)
Spider angioma (central pulsating dilation of arteriole with small vessel radiation)
Hypogonadism (hyperestrogenemia) and gynecomastia
Gynecomastia
Weight loss
Muscle wasting

A

Severe Hepatic Dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
Ascites with peritonitis
Splenomegaly
Esophageal varices
Hemorrhoids
Caput medusae
A

Portal hypertension associated with Cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
Coagulopathy
Hepatic encepalopathy
Hepatorenal syndrome
Portopulmonary hypertension
Hepatopulmonary syndrome
A

Complications of Hepatic failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
Hepatocyte integrity
(Elevation: Liver disease)
A

AST
ALT
LDH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Biliary excretory function

A

Serum bilirubin (Total, Direct, Delta:linked to albumin)
Urine bilirubin
Serum bile acid
Plasma membrane (damage to bile canaliculi)
Serum alkaline phosphatase
Serum gamma glutamyl transpeptidase
Serum 5’ nucleotidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hepatocyte function

A
Serum albumin
Prothrombin time (V,VII,X,PT,fibrinogen)
Hepatocyte metabolism: 
Serum ammonia
Aminopyrine breath test (heptic demethylation)
Galactose elimination (IV injection)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most severe consequence of liver disease, end point of progressive damage
Loss of 80-90% hepatic function
Insidious piecemeal destruction, repetitive waves of parenchymal damage or sudden, massive destruction

A

Hepatic failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drugs or viral hepatitis
Clinical hepatic insuff to hepatic enceph within 2-3 weeks
MASSIVE HEPATIC NECROSIS
Liver transplant

A

Acute Liver Failure with Massive Hepatic Necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most common route to hepatic failure, endpoint of chronic liver damage
Parenchymal, biliary or vascular in origin
Ends in cirrhosis

A

Chronic liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Acute liver failure extending more than 3 months

A

subacute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Viable hepatocyte but unable to perform metabolic function
Mitochondrial injury in Reye syndrome
Acute Fatty Liver of pregnancy
Toxin mediated injury

A

Hepatic dysfunction without overt necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bile two major functions

A

1 primary pathway for elimination of bilirubin, chole and xenobiotics
2 emulsification of fat in gut by bile salt and phospholipid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Yellow discoloration of skin and sclerae icterus occurs when system retention of bilirubin exceeds

A

2 mg/dl jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Systemic retention of bilirubin + BILE SALTS AND CHOLESTEROL

A

Cholestasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Oxidize heme to biliverdin

Biliverdin is reduced to bilirubin by

A

Heme oxygenase

Biliverdin reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bilirubin hepatocyte uptake

A

Carrier mediated uptake at sinusoidal membrane
Cystosolic protein bindingn and delivery to ER
Conjugation with one or two molecules of glucoronic acid by bilirubin UDP GT uridine diphosphate glucuronosyl transferase
Excretion of water soluble nontoxic bilirubin glucuronides into bile (conjugated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Conjugated bilirubin is deconjugated by gut bacterial B glucuronidase and degraded to

A

colorless urobilinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Physiologic jaundice or neonatal jaundice happens bec hepatic machinery for bilirubin conjugation and excretion only matures at around

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Common 7% benign heterogenous inherited mild fluctuating unconjugated hyperbilirubinemia
Dec hepatic levels of glucorosyltransferase from mutation in encoding gene
No morbidity

A

Gilbert Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Autosomal recessive defect in transport protein for hepatocellular excretion of bilirubin glucuronides across canalicular membrane
Exhibit hyperbilirubinemia
Darkly pigmented liver from polymerized epinephrine metabolites
Hepatomegaly without functional problem

A

Dubin-Johnson Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Enzyme in bile duct and canaliculi of hepatocyte

Elevated in cholestasis

A

ALP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hemolytic anemia
Resorption of blood from intestinal hemorrhage
Ineffective EPO syndrome (pernicious, thalassemia)

A

excess bilirubin production

predominantly unconjugated hyperbilirubinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

drug interference with membrane carrier system

diffuse hepatocellular disease (viral, drug induced)

A

reduced hepatic uptake

predominantly unconjugated hyperbilirubinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

physiologic jaundice of newborn

A

Impaired bilirubin conjugation

Predominantly unconjugated hyperbilirubinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Def of canalicular membrane transporter Drug induced canalicular membrane dysfunction (ocp cyclosporine) Hepatocellular damage/toxicity
Dec hepatocellular excretion | Predominantly conjugated hyperbilirubinemia
26
Inflammatory destruction of intrahepatic bile duct (primary sclerosing, graft-vs-host, liver transplant) gallstone, ca of pancreas
Impaired intra or extra-hepatic bile flow | Predominantly conjugated hyperbilirubinemia
27
Most common cause of jaundice involving accumulation of unconjugated bilirubin
Hemolytic anemia
28
Most common cause of jaundice involving accumulation of conjugated bilirubin
Hepatitis intra or extrahepatic obstruction
29
``` Rigidity Hyperreflexia Nonspecific EEG Seizure ASTERIXIS (flapping tremor) nonrhythmic rapid ext and flex movement of head and extremities esp when arms are held in extension with dorsiflexed wrist ```
Hepatic | Encephalopathy
30
Factors contributing to hepatic enceph
severe loss of hepatocellular function | shunting of blood from portal to systemic circulation around chronically diseased liver
31
Key pathogenesis in hepatic enceph
Elevation in blood ammonia Impairing neuronal function and promoting generalized brain edema in acute Deranged neurotrasmitter production monoaminergic, opiodergic, y-aminobutyric acid and endocannabanoid system in chronic
32
Diffuse process characterized by fibrosis and conversion of normal liver architecture to structurally abnormal nodule
Cirrhosis
33
Cirrhosis main characteristics
1 fibrous septa - delicate bands or broad scars around lobules Long standing fibrosis is irreversible as long as vascular shunts are present, regression if cause reversed 2 parenchymal nodule - small to large, encircled by fibrous bands Preexistent hepatocyte displaying replecative senescence at time of fibrosis Newly formed hepatocyte capable of replication gives rise to ductular reactions at periphery of nodules 3 involvement of most of liver
34
3 processes central to pathogenesis of cirrhosis
Death of hepatocyte Extracellular matrix deposition Vascular reorganization
35
In cirrhosis this type of collagen is deposited in space of Disse instead of type IV
Type I & III
36
Major source of excess collagen in cirrhosis normally functioning as storage of Vitamin A Activate and transform to myofibroblast during fibrosis due to ROS, TNF, IL1 and lymphotoxin
Stellate cells of perisinusoid | Ito cells in space of Disse
37
stellate cells produce that initiate fibrosis formation
TGF B
38
Even in late stage disease this may happen significant restoration or remodelling due to dynamic process of ECM synthesis, deposition and resorption by metalloproteases
cirrhotic regression
39
Vascular lesions that contribute to liver function defect
Loss of sinusoidal endothelial fenestration and inc basement membrane formation -> thin walled sinusoid becoming fast flowing vascular channel -> impaired protein movement Portal vein-hepatic vein shunt Hepatic artery-portal vein shunt
40
Dominant intrahepatic cause of portal hypertension
cirrhosis
41
Inc resistance to portal flow and compression of central vein by perivenular fibrosis and parenchymal nodule Inc blood flow to portal vein from vasodilation of splanchnic circulation (hyperdynamic circulation) from inc NO from bacterial DNA Imposed arterial pressure on normally low pressure portal veins
Portal hypertension
42
Collection of excess fluid in peritoneal cavity at least 500 ml to be clinically detectable Serous, 3g/dL of albumin Serum ascites:albumin gradient >/= 1.1 g/dL scant mesothelial cell and mono
Ascites Neutrophilic -infection RBC -cancer Hydrothorax on right from peritoneal fluid seepage through diaphragm lymphatics
43
Ascites pathogenesis
Inc movement of intravascular fluid into spase of Disse by sinusoidal HTN and hypoalbuminemia Leakage of fluid from hepatic interstitium to peritoneum. Hepatic lymph flow >20l (normal 800-1000ml) which is rich in proteins and low in TAG Renal retention of Na and water 2 to hyperaldosteronism despite total body sodium mass more than normal
44
Principal sites of portosystemic shunt
Rectal veins CEJ veins Retroperitoneum and falciform ligament of liver (periumbilical and abdominal)
45
Renal failure without primary abnormality of kidney in severe liver failure bec splanchnic vasodilation and systemic vasoconstriction leading to dec renal blood flow of cortex Dec UO and inc BUN, Crea Hyperosmolar urine devoid of protein and abn sediment (low in sodium) vs RTN Tx: transplant, HD
Hepatorenal syndrome Exclude circulatory collapse
46
Pulmonary arterial HTN assoc with liver disease or portal HTN Excessive pulmo vasocon and vaso remodelling leading to R HF Most common clinical manifestation are
Portopulmonary HTN Hepatopulmonary HTN Dyspnea with severe arterial hypoxemia and cyanosis
47
Pathognomonic of hepatopulmonary HTN
Platypnea (easier breathing while lying down vs sitting and standing) Orthodeoxia (fall of arterial blood oxygen with upright posture)
48
Most common cause of drug induced acute liver failure
Acetaminophen
49
Agent that causes cholestasis in those who metabolize it slowly
chlorpromazine
50
Fatal immune-mediates hepatitis in persons exposed to this anesthetic
Halothane
51
Bland hepatocellular cholestasis without inflamm | OCP, anabolic steroid, ERT use
Cholestatic injury
52
Cholestasis with lobular inflamm and necrosis bile duct destruction Antibiotics Phenothiazine
Cholestatic hepatitis
53
``` Spotty hepatocyte necrosis (methyldopa, phenytoin) Submassive necrosis of zone 3 (acetaminophen, halothane) Massive necrosis (isoniazid, phenytoin) ```
Hepatocellular necrosis
54
Macrovesicular | Ethanol, methotrexate, corticosteroids, TPN
Steatosis
55
Microvesicular Mallory body Amiodarone Ethanol
Steatohepatitis
56
Periportal Pericellular fibrosis Methotrexate, isoniazid, enalapril
Fibrosis | Cirrhosis
57
Noncaseating epitheloid granuloma | Sulfonamide
Granulomas
58
Sinusoidal obstruction Obliteration of central vein (high dose chemo, bush tea) Budd-Chiari (OCP) Sinusoidal dilation (OCP, others) Peliosis hepatis: blood filled cavities not lined by epithelial cell (Anabolic steroids, tamoxifen)
Vascular lesion
59
``` Hepatic adenoma (OCP, anabolic) Hepatocellular CA (Thorotrast) Cholangiocarcinoma (Thorotrast) Angiosarcoma (Thorotrast, vinyl chloride) ```
Neoplasm
60
Nodular masses of liver separated by granulation tissue and scar Nodularity and scarring entire or patchy involvement Mononuclear infiltrates predominate all phases bec of T cell immunity Ballooning degeneration, empty cell with pale cytoplasm rupturing and undergoing necrosis cytolysis (dropped out appearance) and apoptosis eosinophilic shrunk hepatocyte If awat from portal tract and in parenchyma (lobar hepatitis) Central-portal bridging necrosis followed by parenchymal collapse
Hepatitis
61
Minimal or absent portal inflamm
Acute hepatitis
62
Dense MONONUCLEAR portal infiltrate of variable prominence Interface hepatitis Scarring Fibrous septa -> cirrhosis Dx
Chronic hepatitis Liver biopsy
63
Distinction between acute and chronic hep is based on
Pattern of cell injury Severity of inflammation Acute hep- less inflammation and more hepatocyte death than chronic
64
Hexagon centered on a central vein with portal tract at three of its apices Regions: periportal, midzonal, centrilobular
Hepatic lobule
65
Blood supply as reference with portal vessels at their base on the basis of distance from blood supply, 3 zones 1 closest to blood source 2 and 3 farther
Hepatic acinus
66
Appears before onset of symptom Peaks in overt disease Declines undetectable at 3-6 m
HBsAg
67
Does not rise until acute disease is over and not detectable for few weeks to months after disappearance of HBsAg May persist for life conferring immunity Basis for vaccination
Anti-HBs
68
Appear in serum soon after HBsAg Signify active viral replication Persistence indicates continued viral replication infectivity and progression to chronic hepatitis
HBeAg HBV-DNA DNA polymerase
69
Implies that acute infection has peaked and on the wane
anti-Hbe
70
Detectable in serum shortly before the onset of symptoms, concurrent elevation of serum AST ALT Replaced by IgG
IgM Anti-HBc
71
Accumulation of HBsAg in cytoplasm | Large pale finely granular pink cytoplasm inclusions on ER
Ground glass hepatocyte in chronic hep B
72
Fatty change from altered lipid metab Lymphoid infiltrates in portal tract with fully formed lymphoid follicle Bile duct injury by direct infection of cholangiocyte
Hepatitis C
73
Pathognomonic of yellow fever | Apoptosis of hepatocyte, eosinophilic
Councilman bodies
74
Only causes acute hepatitis
Hepa A | Hepa E
75
Cause chronic hepatitis
Hepa B, C, D
76
Inflammatory cells in both acute and chronic Hep | Difference in pattern of injury
T cell
77
Most important for grading and staging of disease used to decide whether px will undergo antiviral tx
Liver biopsy in chronic hep
78
``` sSRNA Hepatovirus, Picornavirus Fecal oral Incubation: 2-6 w Freq of chronic liver disease: Never Lab dx: Detection of serum IgM ```
Hepatitis A
79
``` Partially dsDNA Hepadnavirus Parenteral, sexual contact, perinatal Incubation: 4-26w Freq of chronic liver: 10% Dx: Detection of HBsAg or HBcAg ab ```
Hepatitis B
80
ssRNA Flaviridae Parenteral, intranasal cocaine use is risk factor Incubation: 2-26w Freq of chronic liver disease: 80% Dx: PCR assay for HCV RNA, 3rd gen ELISA for ab detection
Hepatitis C
81
Circular defective ssRNA Subviral particle in Deltaviridae Parenteral Incubation: 4-26w Freq of chronic liver: 5% coinfec, = 70% for superinfection Dx: Detection of IgM and IgG ab, HDV RNA serum, HDAg liver
Hepatitis D
82
``` ssRNA Hepevirus Fecal-oral Incubation: 2-8 weeks Freq of chronic liver: Never Laboratory diagnosis: PCR assay for HEV RNA, detection of IgM and IgG ```
Hepatitis E
83
Female, absent viral serology, inc IgG, high autoantibody, autoimmune disease (RA, Sjogren’s) Early phase of severe cell injury and inflamm followed by rapid scarring (early wave of hepatocyte damage and necrosis) Very severe hepatocyte injury with confluent necrosis Marked inflammation with advanced scarring Burned out cirrhosis with Little ongoing cell injury or inflamm Mononuclear infiltrate with abundant PLASMA CELL Responds to immunosuppresive therapy
Autoimmune hepatitis
84
Drugs that induce autoimmune hepatitis
Minocycline | Nitrofurantoin
85
Fatty liver disease (3)
Steatosis Hepatitis Fibrosis
86
Fat accumulation begins in centrilobular area | Small to large dropleta filling and expanding cell displacing the nucleus (central vein -> hepatocyte)
Hepatocellular steatosis
87
More pronounced with alcohol use than NAFLD
Steatohepatitis with ballooning, Mallory-Denk, neutrophil infiltration
88
Single or scattered foci of cells undergoing swelling and necrosis Most prominent in centrilobular region
Hepatocyte ballooning
89
Tangled skeins of intermediate filament (ubiquinated keratin of 8 and 18) Visible eosinophilic cytoplasmic inclusion in hepatocyte
Mallory-Denk body
90
Neutrophilic infiltration permeating the lobule and accumulating degenerating hepatocyte Lymph and mac un portal tract
Neiutrophil infiltration
91
Fatty liver disease on histology may appear | Fibrosis on perisinusoids
chicken wire fence pattern
92
Fibrosis(central vein sclerosis) then Space of disse outwards becoming chicken wire fence creating central-portal fibrous septa Liver becomes nodular, cirrhotic Micronodular cirrhosis Cryptogenic cirrhosis - burned out NASH
Fatty liver disease Laennec cirrhosis
93
Hepatic steatosis Alcoholic hepatits Fibrosis and cirrhosis
Alcoholic fatty liver disease
94
Ingestion of this amount of ethanol produce mild hepatic change (fatty liver) Chronic intake of this amount is norderline risk factor for severe
80g 40-80g/day
95
Metabolite of ethanol that induces lipid peroxidation and acetal-dehyde protein adduct for maturation disrupting cytoskeleton and membrane function
Acetaldehyde
96
Generated during oxidation of ethanol by microsomal ethanol oxidizing system reacting with damage membranes and protein
ROS
97
Major feature of alcoholic hepatitis and liver disease TNF is main effector of injury IL1, 6 and 8
Cytokine mediated inflammation
98
Most susceptibe region to toxic injury
Centrilobular
99
Major accelerator of liver disease in alcoholic
Concurrent Hepa C
100
In patients with metabolic syndrome, the best predictor of severe fibrosis and disease progression in NAFLD are
Type 2 DM Obesity Others: HTN, Dyslipidemia